MPR highlights health innovations from the 2021 Consumer Electronics Show (CES).
A woman presents for evaluation of a rash affecting both feet that prevents her from walking properly because of pain.
An expert panel assessed 39 diets to come up with the final results, examining the evidence behind each diet’s claims.
The approval was based on data from the pivotal phase 3 EMPOWUR study.
Cross-sectional data from the National Health and Nutrition Examination Survey from 1988 to 1994 and 1999 to 2016 were used for this analysis.
An algorithm to help guide the interpretation of blood test results in order to identify patients with prediabetes and prevent the development of diabetes.
The FDA has approved Saxenda® (liraglutide; Novo Nordisk) as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in patients aged 12 years and older with body weight >60kg and an initial BMI corresponding to ≥30kg/m2 for adults (obese).
Convalescent plasma therapy may “potentiate the increased thrombotic risk and endotheliopathy” thought to contribute to disease pathophysiology in COVID-19.
A comparative list of treatment options for arthritis including DMARDS and other immune modulators.
The patient, a 67-year-old female, presented to the emergency department with altered mental status.